Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Alternative hormone therapy in postmenopause].

Ivan Fistonić1, Tomislav Canić, Zeljko Duić

  • 1Ginekoloska ordinacija, Zagreb. ivan.fistonic@zg.htnet.hr

Lijecnicki Vjesnik
|July 1, 2006
PubMed
Summary

Postmenopausal hormone therapy (HT) use declined due to risks. Current recommendations favor individualized, lower-dose HT and exploring non-estrogen treatments, supported by evidence-based alternative therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

SMOKING EFFECT ON OXIDATIVE STRESS AND ANTIOXIDANT CAPACITY OF CERVICAL MUCUS IN WOMEN WITH PRIMARY IDIOPATHIC STERILITY - OBSERVATIONAL CASE-CONTROL STUDY.

Acta clinica Croatica·2025
Same author

Chronic kidney disease and menopausal health: An EMAS clinical guide.

Maturitas·2024
Same author

Sexual health and wellbeing and the menopause: An EMAS clinical guide.

Maturitas·2024
Same author

Literature review and case report: Rare case of successful prenatal detection of Vein of Galen Malformation (VGAM).

European journal of obstetrics & gynecology and reproductive biology: X·2024
Same author

EMAS position statement: Thyroid disease and menopause.

Maturitas·2024
Same author

Fragility spinal fractures among cirrhotic liver transplant candidates in Croatia.

Injury·2023

Area of Science:

  • Reproductive Medicine
  • Endocrinology
  • Oncology

Context:

  • The Women's Health Initiative (WHI) study significantly impacted postmenopausal hormone therapy (HT) prescribing.
  • HT, particularly estrogen-plus-progestogen, has been linked to increased risks of cancer, stroke, and heart disease.
  • These findings led to a decline in HT use and a shift in clinical recommendations.

Purpose:

  • To review the impact of major studies on postmenopausal hormone therapy.
  • To explore alternative and complementary treatments for menopausal symptoms.
  • To highlight evidence-based non-estrogen options for climacteric medicine.

Summary:

  • Major studies, including the WHI, revealed increased health risks associated with traditional postmenopausal hormone therapy (HT).

Related Experiment Videos

  • This has led to a re-evaluation of HT, emphasizing individualized treatment, lower dosages, and consideration of non-estrogen alternatives.
  • The review focuses on evidence-based alternative and complementary therapies supported by randomized controlled trials.

    • Impact:

    • Reduced reliance on traditional, higher-dose HT for menopausal symptom management.
    • Increased interest and research into safer, non-estrogen-based treatments for menopause.
    • Provides clinicians and patients with evidence-based options for managing menopausal symptoms, prioritizing safety and individual needs.